PS Ratio
N/A
Tue, 07 Jan 2025 00:59:15 GMT
Summary:
Seres Therapeutics price to sales ratio is not available.MCRB PS Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MCRB PS Ratio Performance
| PeriodPeriod | PS ratioPS ratio | PricePrice | Market capMarket cap | TTM revenueTTM revenue |
|---|---|---|---|---|
| todaytoday | - | -0.4% | -0.4% | - |
| 1 m1 month | - | +9.7% | +9.7% | - |
| 3 m3 months | - | +5.8% | +6.1% | - |
| 6 m6 months | - | +9.4% | +23.1% | - |
| ytdytd | - | +11.2% | +11.2% | - |
| 1 y1 year | - | -35.7% | -18.7% | - |
| 5 y5 years | - | -72.4% | -32.7% | - |
MCRB PS Ratio High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | ||||
| 3 m | 3 months | ||||
| 6 m | 6 months | ||||
| 1 y | 1 year | 0.84 | 0.45 | ||
| 3 y | 3 years | 167.51 | 0.45 | ||
| 5 y | 5 years | 167.51 | 0.45 | ||
| alltime | all time | 503.11 | 0.45 |
Seres Therapeutics PS Ratio History
| Date | Value |
|---|---|
| 2023 | 0.76(-99.2%) |
| 2022 | 97.85(+1767.4%) |
| 2021 | 5.24(-92.2%) |
| 2020 | 67.46(+862.3%) |
| Date | Value |
|---|---|
| 2019 | 7.01(+7.0%) |
| 2018 | 6.55(-48.9%) |
| 2017 | 12.82(-30.2%) |
| 2016 | 18.36 |
FAQ
- What is the all time high PS ratio for Seres Therapeutics?
What is the all time high PS ratio for Seres Therapeutics?
Seres Therapeutics all-time high price to sales ratio is 503.11